SCHEMBL21348635

SCHEMBL21348635

OCC1CC[C@H](n2ncc3c(NC4CCCC4)nc(Cl)nc32)O1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NT5E P21589 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27414417 1.00 NT5E (0.53) NT5E
SCHEMBL27414597 0.88 NT5E (0.54) NT5E
SCHEMBL27414436 0.88 NT5E (0.54) NT5E
SCHEMBL27270267 0.85 NT5E (0.52) NT5E
SCHEMBL27414528 0.84 NT5E (0.52) NT5E
SCHEMBL27270852 0.82 NT5E (0.53) NT5E
SCHEMBL27270841 0.82 NT5E (0.53) NT5E
SCHEMBL23337026 0.81 NT5E (0.55) NT5E
SCHEMBL19366702 0.80 NT5E (0.73) NT5E
SCHEMBL23915097 0.80 NT5E (0.73) NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019173682-A1 PARENTERALLY ADMINISTERED IMMUNE ENHANCING DRUGS ARCUS BIOSCIENCES, INC. (US) 2019-09-12 WO disclosed